Innova Captab IPO GMP Today, Date, Review

4.7/5 - (4 votes)

In this article we will discuss Innova Captab GMP today’s live allotment date, allotment status, subscription status and complete review, so read it carefully before applying for this IPO.

Innova Captab IPO

Innova Captab IPO Review

IPO NameInnova Captab
Issue TypeBook Built IPO
Market Cap₹2563.7 Cr.
IPO Size₹570.00 Cr.
(Total 12,723,214 Share)
Price Band₹426 to ₹448 / Share
Face Value₹10 / Share
Lot Size33 Shares
PE Ratio31.64
Listing OnNSE & BSE

Indian pharmaceutical company Innova Captab’ has submitted an IPO of ₹570.00 Cr open on 21st December to 26th December with a Price band of ₹426-₹448 worth of 33 shares per lot.

Innova Captab IPO list on NSE and BSE on 29th December at 10 AM. ICICI Securities and JM Financial Limited are merchant banks and KFinTech is the registrar of this IPO.

IPO Open Date21 December 2023
IPO Last Date26 December 2023
*till 4:50 PM
Allotment status27 December 2023
Refund Initiate28 December 2023
Share Credit to Demat28 December 2023
Listing On Exchange29 December 2023

You can apply for this IPO through your Demat account from 21st December to 26th December. On 27th December you will get allotment status whether you are allotted a share or not.

Share allotment status and the latest GMP are updated on the Telegram channel so click here and Join our Telegram Channel.

Anchor InvestorAllotted (%)
Anchor Inveastor30%

Qualified institution buyers (QIBs) are big institutes like Mutual Funds, etc. S-HNI investors are below 10 lakh and, B-HNI invest more than 10 lakh. Anchor investor list uploaded on Telegram channel

Retail (Min)133₹14,784
Retail (Max)13429₹192,192
S-HNI (Min)14462₹206,976
S-HNI (Max)672211₹990,528
B-HNI (Min)682244₹1,005,312

If you are a retail investor then you can apply a minimum of 1 lot with ₹14784 (Minimum Investment)

Post P/E36.42
Reserve & SurplusJune 2023March 2023March 2022March 2021
Reserve & Surpluss317.51228.51196.61132.82
Net WorthReserve & Surplus276.46208.56144.78
Note – Amount in Crores(₹).

Founded in 2005, Innova Captab is a Pharmaceutical manufacturing company. The founder is Vinay Kumar Lohariwala. Innova Captab is involved in Three Types of business in pharmaceuticals – The first is contract development manufacturing (CDM) for the other Indian top Pharmaceutical brands. Second is manufacturing and selling under its own brand Innova Captab and third is manufacturing and sale in the international market.

Currently, Innova Captab is supplying top Indian Medicine brands like Cipla, Mankind, Glenmark, Lupin, Medley Pharmaceuticals, Eris Healthcare, Zuventus Healthcare, Ajanta Pharma, etc.

₹320 Cr. is a fresh issue IPO and ₹250 Cr. is an offer for sale. The objective of an IPO is the repayment of the loan while acquiring other companies, investing in the subsidiaries and funding the working capital requirements.

Pros and Cons

  • Positive
    • Wide range of products over 1100.
    • The pharmaceutical industry is growing rapidly after COVID
    • Mostly B2B Business with large companies, so stable customers.
    • Also, Export Internationally to over 20 Countries.
    • Largest CDMOs in the Indian Pharmaceutical industry.
    • recently invested in Jammu and Kashmir to be exempt from GST by GoI regulations.
  • Negative
    • Dependent on large companies.
    • competitive market
    • Low margins in comparison to other pharma companies.
    • dependent on China for raw materials.

Final Decision

According to the current GMP and overall company’s financials and business in pharma is a plus point for Innova Captab to invest in IPO for Listing gain as well good returns in the upcoming 2-3 years. consult your financial advisor before investing in an IPO. We are discussing based on data.

If you like this article, then share it with Your Friends.

1 thought on “Innova Captab IPO GMP Today, Date, Review”

Leave a Comment